ellipticine has been researched along with Breast Cancer in 16 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of vasoactive intestinal peptide (VIP)-ellipticine (E) derivatives were investigated on breast cancer cells." | 7.71 | VIP-ellipticine derivatives inhibit the growth of breast cancer cells. ( Czerwinski, G; Michejda, CJ; Moody, TW; Tarasova, NI, 2002) |
| "Targeting breast cancer stem cells (BCSCs) offers a promising strategy for breast cancer treatment." | 5.40 | Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells--an in vitro and in silico study. ( Banarji, A; Chauhan, PS; Chikati, R; Kumar, CS; Pandrangi, SL; Saxena, S, 2014) |
| "The effects of vasoactive intestinal peptide (VIP)-ellipticine (E) derivatives were investigated on breast cancer cells." | 3.71 | VIP-ellipticine derivatives inhibit the growth of breast cancer cells. ( Czerwinski, G; Michejda, CJ; Moody, TW; Tarasova, NI, 2002) |
| "Targeting breast cancer stem cells (BCSCs) offers a promising strategy for breast cancer treatment." | 1.40 | Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells--an in vitro and in silico study. ( Banarji, A; Chauhan, PS; Chikati, R; Kumar, CS; Pandrangi, SL; Saxena, S, 2014) |
| "Ellipticine treatment increased the expression of Fas/APO-1 and its ligands, mFas ligand and sFas ligand, and subsequent activation of caspase-8." | 1.33 | The mechanism of ellipticine-induced apoptosis and cell cycle arrest in human breast MCF-7 cancer cells. ( Chang, CH; Hsu, YL; Kuo, PL; Lin, CC, 2005) |
| "Ellipticine treatment arrested MDA-MB-231 cells at the G2/M phase after 6 h of treatment." | 1.33 | The anti-proliferative inhibition of ellipticine in human breast mda-mb-231 cancer cells is through cell cycle arrest and apoptosis induction. ( Chang, CH; Hsu, YL; Kuo, PL; Kuo, YC; Lin, CC, 2005) |
| "MCF-7 human breast cancer cells, selected for resistance to adriamycin (AdrR), exhibit the phenotype of multidrug resistance (MDR)." | 1.27 | Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line. ( Averbuch, SD; Baird, WM; Cowan, KH; Fairchild, CR; Ivy, SP; Myers, CE; Nebert, DW; Tulpule, A, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delbarre, A | 1 |
| Oberlin, R | 1 |
| Roques, BP | 1 |
| Borgna, JL | 1 |
| Rochefort, H | 1 |
| Le Pecq, JB | 1 |
| Jacquemin-Sablon, A | 1 |
| Devraj, R | 1 |
| Barrett, JF | 1 |
| Fernandez, JA | 1 |
| Katzenellenbogen, JA | 1 |
| Cushman, M | 1 |
| Al-Trawneh, SA | 2 |
| Zahra, JA | 2 |
| Kamal, MR | 1 |
| El-Abadelah, MM | 2 |
| Zani, F | 2 |
| Incerti, M | 2 |
| Cavazzoni, A | 2 |
| Alfieri, RR | 1 |
| Petronini, PG | 1 |
| Vicini, P | 2 |
| Al-Taweel, SA | 1 |
| Rizza, P | 1 |
| Pellegrino, M | 1 |
| Caruso, A | 2 |
| Iacopetta, D | 2 |
| Sinicropi, MS | 2 |
| Rault, S | 2 |
| Lancelot, JC | 1 |
| El-Kashef, H | 2 |
| Lesnard, A | 1 |
| Rochais, C | 1 |
| Dallemagne, P | 2 |
| Saturnino, C | 2 |
| Giordano, F | 1 |
| Catalano, S | 1 |
| Andò, S | 1 |
| Ceramella, J | 1 |
| Occhiuzzi, MA | 1 |
| Barbarossa, A | 1 |
| Rizzuti, B | 1 |
| Grande, F | 1 |
| Ghosh, S | 1 |
| Kar, A | 1 |
| Chowdhury, S | 1 |
| Dasgupta, D | 1 |
| Pandrangi, SL | 1 |
| Chikati, R | 1 |
| Chauhan, PS | 1 |
| Kumar, CS | 1 |
| Banarji, A | 1 |
| Saxena, S | 1 |
| Sedlacek, O | 1 |
| Kucka, J | 1 |
| Mattova, J | 1 |
| Parizek, M | 1 |
| Studenovsky, M | 1 |
| Zadinova, M | 1 |
| Pouckova, P | 1 |
| Hruby, M | 1 |
| Kuo, PL | 2 |
| Hsu, YL | 2 |
| Chang, CH | 2 |
| Lin, CC | 2 |
| Kuo, YC | 1 |
| Oster, JB | 1 |
| Creasey, WA | 1 |
| Sureau, F | 1 |
| Moreau, F | 1 |
| Millot, JM | 1 |
| Manfait, M | 1 |
| Allard, B | 1 |
| Aubard, J | 1 |
| Schwaller, MA | 1 |
| Moody, TW | 1 |
| Czerwinski, G | 1 |
| Tarasova, NI | 1 |
| Michejda, CJ | 1 |
| Vickers, PJ | 1 |
| Dufresne, MJ | 1 |
| Cowan, KH | 2 |
| Ivy, SP | 1 |
| Tulpule, A | 1 |
| Fairchild, CR | 1 |
| Averbuch, SD | 1 |
| Myers, CE | 1 |
| Nebert, DW | 1 |
| Baird, WM | 1 |
16 other studies available for ellipticine and Breast Cancer
| Article | Year |
|---|---|
Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer.
Topics: Alkaloids; Animals; Breast Neoplasms; Cattle; Cell Line; DNA; Ellipticines; Female; Humans; In Vitro | 1985 |
Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Survival; Central Nerv | 1996 |
Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell | 2010 |
Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell | 2011 |
3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.
Topics: Antineoplastic Agents; Apoptosis; Benzofurans; Breast Neoplasms; Cell Line, Tumor; Chemistry Techniq | 2016 |
Benzothienoquinazolinones as new multi-target scaffolds: Dual inhibition of human Topoisomerase I and tubulin polymerization.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; DNA Topoisomerases, Type I; Drug Design; | 2019 |
Ellipticine binds to a human telomere sequence: an additional mode of action as a putative anticancer agent?
Topics: Antineoplastic Agents; Breast Neoplasms; Calorimetry, Differential Scanning; Cell Line, Tumor; Circu | 2013 |
Effects of ellipticine on ALDH1A1-expressing breast cancer stem cells--an in vitro and in silico study.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Amino Acid Sequence; Antineoplastic Agents; | 2014 |
Multistage-targeted pH-responsive polymer conjugate of Auger electron emitter: optimized design and in vivo activity.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Drug Delivery Systems; Drug Screening Assays, Anti | 2014 |
The mechanism of ellipticine-induced apoptosis and cell cycle arrest in human breast MCF-7 cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carrier Proteins; Cell Cycle; Cell Proliferation | 2005 |
The anti-proliferative inhibition of ellipticine in human breast mda-mb-231 cancer cells is through cell cycle arrest and apoptosis induction.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell P | 2005 |
Enhancement of cellular uptake of ellipticine by insulin preincubation.
Topics: Alkaloids; Animals; Breast Neoplasms; Cell Survival; Cells, Cultured; DNA; Dose-Response Relationshi | 1981 |
Microspectrofluorometry of the protonation state of ellipticine, an antitumor alkaloid, in single cells.
Topics: Biophysical Phenomena; Biophysics; Breast Neoplasms; Chromatin; DNA, Neoplasm; Ellipticines; Female; | 1993 |
VIP-ellipticine derivatives inhibit the growth of breast cancer cells.
Topics: Amino Acid Sequence; Breast Neoplasms; Cell Division; Ellipticines; Humans; Molecular Sequence Data; | 2002 |
Relation between cytochrome P450IA1 expression and estrogen receptor content of human breast cancer cells.
Topics: Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Breast Neoplasms; Cell Nucleus; Cytochrome P-450 Enzy | 1989 |
Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell line.
Topics: Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Blotting, Northern; Breast Neoplasms; Cell Line; Chlo | 1988 |